...
首页> 外文期刊>Journal of tissue engineering and regenerative medicine >Porous titanium scaffolds with injectable hyaluronic acid-DBM gel for bone substitution in a rat critical-sized calvarial defect model
【24h】

Porous titanium scaffolds with injectable hyaluronic acid-DBM gel for bone substitution in a rat critical-sized calvarial defect model

机译:多孔钛支架具有可注射透明质酸-DBM凝胶的骨替代大鼠临界大小的颅骨缺陷模型

获取原文
获取原文并翻译 | 示例

摘要

Demineralized bone matrix (DBM) is an allograft bone substitute used for bone repair surgery to overcome drawbacks of autologous bone grafting, such as limited supply and donor-site comorbidities. In view of different demineralization treatments to obtain DBM, we examined the biological performance of two differently demineralized types of DBM, i.e. by acidic treatment using hydrochloric acid (HCl) or treatment with the chelating agent ethylene diamine tetra-acetate (EDTA). First, we evaluated the osteo-inductive properties of both DBMs by implanting the materials subcutaneously in rats. Second, we evaluated the effects on bone formation by incorporating DBM in a hyaluronic acid (HA) gel to fill a porous titanium scaffold for use in a critical-sized calvarial defect model in 36 male Wistar rats. These porous titanium scaffolds were implanted empty or filled with HA gel containing either DBM HCl or DBM EDTA. Ectopically implanted DBM HCl and DBM EDTA did not induce ectopic bone formation over the course of 12weeks. For the calvarial defects, mean percentages of newly formed bone at 2weeks were significantly higher for Ti-Empty compared to Ti-HA+DBM HCl, but not compared to Ti-HA+DBM EDTA. Significant temporal bone formation was observed for Ti-Empty and Ti-HA+DBM HCl, but not for Ti-HA+DBM EDTA. At 8weeks there were no significant differences in values of bone formation between the three experimental constructs. In conclusion, these results showed that, under the current experimental conditions, neither DBM HCl nor DBM EDTA possess osteo-inductive properties. Additionally, in combination with an HA gel loaded in a porous titanium scaffold, DBM HCl and DBM EDTA showed similar amounts of new bone formation after 8weeks, which were lower than using the empty porous titanium scaffold. Copyright (C) 2016 John Wiley & Sons, Ltd.
机译:脱矿质骨基质(DBM)是用于骨修复手术的同种异体移植骨替代物,以克服自体骨移植的缺点,例如有限的供应和供体现场合并症。鉴于获得DBM的不同脱矿化治疗,我们研究了两种不同脱矿化类型的DBM的生物学性能,即使用盐酸(HCl)的酸性处理或用螯合剂乙烯二胺四乙酸酯(EDTA)处理。首先,通过在大鼠中皮下植入材料来评估两种DBMS的骨感应性质。其次,我们通过将DBM掺入透明质酸(HA)凝胶中的DBM来评估对骨形成的影响,以填充多孔钛支架,用于36只雄性Wistar大鼠中的临界大小的颅骨缺陷模型。这些多孔钛支架被植入空或填充有含有DBM HCl或DBM EDTA的HA凝胶。异位植入的DBM HCl和DBM EDTA在12周内没有诱导异位骨形成。对于Calvarial缺陷,与Ti-Ha + DBM HCl相比,Ti-Ha + DBM HCL的Ti-amply的新形成骨的平均百分比显着更高,但与Ti-Ha + dBM EDTA相比,Ti-Ha +。对于Ti-空和Ti-HA + DBM HCl观察到显着的颞骨形成,但不适用于Ti-Ha + dBM EDTA。在8周上,三种实验构建体之间的骨形成值没有显着差异。总之,这些结果表明,在目前的实验条件下,DBM HCl和DBM EDTA都没有具有骨感应性能。另外,与在多孔钛支架中的HA凝胶组合,DBM HCl和DBM EDTA在8周后显示出类似的新骨形成,其低于使用空多孔钛支架。版权所有(c)2016 John Wiley&Sons,Ltd。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号